FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 72888-032 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAdvagen Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA214415
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (15 mg/1)
Marketing started20201027
Package count2

External sources

Source: openFDA. Public-domain (CC0).